Anthony Li (@dranthonyli) 's Twitter Profile
Anthony Li

@dranthonyli

Consultant Cardiologist and Electrophysiologist. 🇬🇧 St. George’s Hospital. #EHRA_ESC e-communications committee member

ID: 1143964853268357122

linkhttp://www.heartrhythmdoctor.net calendar_today26-06-2019 19:30:49

304 Tweet

332 Followers

355 Following

EHRAPresident (@ehrapresident) 's Twitter Profile Photo

#EHRA_ESC brings you today a must-read for cardiologists: Characteristics and prognosis of electrical storm⚡️ during AMI!🫀 This Europace Editor-in-Chief manuscript included 151 patients from centers in France 🇫🇷 ES ⚡ was defined as: • Three or more sustained VT/VF within 24hs ⚡ •

#EHRA_ESC brings you today a must-read for cardiologists: Characteristics and prognosis of electrical storm⚡️ during AMI!🫀

This <a href="/EuropaceEiC/">Europace Editor-in-Chief</a>  manuscript included 151 patients from centers in France 🇫🇷
ES ⚡ was defined as:
• Three or more sustained VT/VF within 24hs ⚡
•
EHRAPresident (@ehrapresident) 's Twitter Profile Photo

Today, #EHRA_ESC brings you a sub-analysis of the STABLE-SR-II trial exploring benefits of low-voltage area ablation in persistent AF STABLE-SR-II is a multicentre, single-blinded, randomized controlled trial comparing PVI alone vs PVI + LVA (0.1–0.4 mV) ablation This

Today, #EHRA_ESC brings you a sub-analysis of the STABLE-SR-II trial exploring benefits of low-voltage area ablation in persistent AF

STABLE-SR-II is a multicentre, single-blinded, randomized controlled trial comparing PVI alone vs PVI + LVA (0.1–0.4 mV) ablation

This
EHRAPresident (@ehrapresident) 's Twitter Profile Photo

Kicking off #EHRAtopicweek on SCD in Heart Failure! New #EHRA_ESC 🎙️Cardiotalk podcast 🚨 Tune in to the interview hosted by Stefan Simović and Micaela Ebert discussing risk stratification of SCD with David Duncker and Marco Metra bit.ly/3L18CD7 European Society of Cardiology HFAPresident

Kicking off #EHRAtopicweek on SCD in Heart Failure!

New #EHRA_ESC 🎙️Cardiotalk podcast 🚨

Tune in to the interview hosted by <a href="/simovicst/">Stefan Simović</a> and <a href="/micaela_ebert/">Micaela Ebert</a> discussing risk stratification of SCD with <a href="/DavidDuncker/">David Duncker</a> and <a href="/MarcoMetra/">Marco Metra</a>

bit.ly/3L18CD7

<a href="/escardio/">European Society of Cardiology</a> <a href="/HFA_President/">HFAPresident</a>
EHRAPresident (@ehrapresident) 's Twitter Profile Photo

#EHRAtopicweek on SCD in HF SCD risk in HF: Are we missing patients? 📉 Current ICD eligibility hinges on LVEF ≤35% ⚠️ But many SCDs strike above that threshold 📚 SCD-HeFT backed ICDs in both ischemic & non-ischemic HF 🤔 DANISH trial challenged the benefit in non-ischemic HF

#EHRAtopicweek on SCD in HF

SCD risk in HF: Are we missing patients?

📉 Current ICD eligibility hinges on LVEF ≤35%
⚠️ But many SCDs strike above that threshold
📚 SCD-HeFT backed ICDs in both ischemic &amp; non-ischemic HF
🤔 DANISH trial challenged the benefit in non-ischemic HF
EHRAPresident (@ehrapresident) 's Twitter Profile Photo

💥#EHRAtopicweek on SCD prevention in HF 💡 Did you know? Optimizing GDMT doesn’t just improve symptoms — it saves lives by reducing SCD 💊 ACEi/ARB/ARNI, beta-blockers, MRAs, SGLT2i = proven SCD protection 📈 The HF-OPT study by Christian Veltmann & David Duncker shows that

💥#EHRAtopicweek on SCD prevention in HF

💡 Did you know? Optimizing GDMT doesn’t just improve symptoms — it saves lives by reducing SCD

💊 ACEi/ARB/ARNI, beta-blockers, MRAs, SGLT2i = proven SCD protection

📈 The HF-OPT study by <a href="/DrV_Mann/">Christian Veltmann</a> &amp; <a href="/DavidDuncker/">David Duncker</a>  shows that
EHRAPresident (@ehrapresident) 's Twitter Profile Photo

#EHRAtopicweek on SCD prevention in HF The future of SCD prevention goes beyond ejection fraction🔮 🧠 AI, computational modeling & genomics are redefining risk stratification: • AI-enabled ECGs predict LV dysfunction 👉 bit.ly/45H1w2q • Smartwatch ECGs do too 👉

#EHRAtopicweek on SCD prevention in HF

The future of SCD prevention goes beyond ejection fraction🔮

🧠 AI, computational modeling &amp; genomics are redefining risk stratification:
• AI-enabled ECGs predict LV dysfunction 👉 bit.ly/45H1w2q
• Smartwatch ECGs do too 👉
EHRAPresident (@ehrapresident) 's Twitter Profile Photo

The MORE-CRT MPP randomized trial shows that multipoint pacing reduced all-cause mortality & HF hospitalizations in prior non-responders to conventional BiV pacing! ⬇️🪦🏥 Check out! 🔗 tinyurl.com/2zjmxppb Europace Editor-in-Chief Haran Burri Boriani Giuseppe

The MORE-CRT MPP randomized trial shows that multipoint pacing reduced all-cause mortality &amp; HF hospitalizations in prior non-responders to conventional BiV pacing! ⬇️🪦🏥

Check out! 🔗 tinyurl.com/2zjmxppb

<a href="/EuropaceEiC/">Europace Editor-in-Chief</a> <a href="/HaranBurri/">Haran Burri</a> <a href="/BorianiGiuseppe/">Boriani Giuseppe</a>
EHRAPresident (@ehrapresident) 's Twitter Profile Photo

#EHRAtopicweek on State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025 Listen to the latest #EHRA_ESC Cardio Talk episode! 🎙️ Join experts Emma Svennberg and Sabine Ernst as they discuss with hosts of the podcast Dominik Linz and Stefan Simović

#EHRAtopicweek on State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025

Listen to the latest #EHRA_ESC Cardio Talk episode!

🎙️ Join experts <a href="/EmmaSvennberg/">Emma Svennberg</a> and Sabine Ernst as they discuss with hosts of the podcast <a href="/Dominik_Linz/">Dominik Linz</a> and <a href="/simovicst/">Stefan Simović</a>
EHRAPresident (@ehrapresident) 's Twitter Profile Photo

#EHRAtopicweek How we use #AI in EP now? TAILORED- AF RCT on individualized #AI-guided ablation of #AF 🔹 374 pts randomized: 188 tailored vs 186 anatomical 🔹 AI-guided ablation + PVI > PVI alone for 1-year freedom from AF in persistent/long-standing AF 🔗

#EHRAtopicweek
How we use #AI in EP now?

TAILORED- AF RCT on individualized #AI-guided ablation of #AF
🔹 374 pts randomized: 188 tailored vs 186 anatomical
🔹 AI-guided ablation + PVI &gt; PVI alone for 1-year freedom from AF in persistent/long-standing AF

🔗
EHRAPresident (@ehrapresident) 's Twitter Profile Photo

🚀 Boost your career with FEHRA! 📅Applications open until 15 October 🔗 bit.ly/4mcN9bB ✅ Prestigious FEHRA title ✅ Free EHRA Congress registration ✅ Access to grants, fellowships & training ✅ Discounts on exams, courses & books ✅ Subscription to EP Europace

🚀 Boost your career with FEHRA!

📅Applications open until 15 October
🔗 bit.ly/4mcN9bB

✅ Prestigious FEHRA title
✅ Free EHRA Congress registration
✅ Access to grants, fellowships &amp; training
✅ Discounts on exams, courses &amp; books
✅ Subscription to EP Europace
Stefan Simović (@simovicst) 's Twitter Profile Photo

lina marcantoni Dominik Linz Priya Bhardwaj Vera Maslova Augusto Meretta Haran Burri Óscar Cano on CSP will replace BiVp: PRO 1️⃣ Both observational & randomized data show benefit of CSP and CSP larger randomized trials are ongoing 2️⃣Procedural endpoints are clearly defined in CSP, while still unclear in BiVp 3️⃣CSP is more simplified procedure than BiVp 4️⃣Not

<a href="/LinaMarcantoni/">lina marcantoni</a> <a href="/Dominik_Linz/">Dominik Linz</a> <a href="/PriyaPBK/">Priya Bhardwaj</a> <a href="/veramasloo/">Vera Maslova</a> <a href="/AugustoMeretta/">Augusto Meretta</a> <a href="/HaranBurri/">Haran Burri</a> <a href="/OCanoPerez/">Óscar Cano</a> on CSP will replace BiVp: PRO

1️⃣ Both observational &amp; randomized data show benefit of CSP and CSP larger randomized trials are ongoing
2️⃣Procedural endpoints are clearly defined in CSP, while still unclear in BiVp
3️⃣CSP is more simplified procedure than BiVp
4️⃣Not
Stefan Simović (@simovicst) 's Twitter Profile Photo

lina marcantoni Dominik Linz Priya Bhardwaj Vera Maslova Augusto Meretta Haran Burri Óscar Cano Jacopo Imberti Fritz Prinzen on CON side of CSP will replace BiVp 1️⃣ Larger randomized trials needed 2️⃣ LBBAP is not effective in IVCD 3️⃣ Definition of LBBAP capture are too complex #ESCCongress

<a href="/LinaMarcantoni/">lina marcantoni</a> <a href="/Dominik_Linz/">Dominik Linz</a> <a href="/PriyaPBK/">Priya Bhardwaj</a> <a href="/veramasloo/">Vera Maslova</a> <a href="/AugustoMeretta/">Augusto Meretta</a> <a href="/HaranBurri/">Haran Burri</a> <a href="/OCanoPerez/">Óscar Cano</a> <a href="/JacopoImberti/">Jacopo Imberti</a> Fritz Prinzen on CON side of CSP will replace BiVp

1️⃣ Larger randomized trials needed
2️⃣ LBBAP is not effective in IVCD
3️⃣ Definition of LBBAP capture are too complex 

#ESCCongress
EHRAPresident (@ehrapresident) 's Twitter Profile Photo

🎙️ Listen to the latest #EHRA_ESC CardioTalk Keep the Rhythm podcast episode on 2025 ESC-EHRA Atlas on Heart Rhythm Disorders! Join experts Daniel Scherr, Michal Farkowski, Stefan Simović & Vera Maslova as they discuss current landscape of #EP in Europe 🇪🇺 🔗

🎙️ Listen to the latest #EHRA_ESC CardioTalk Keep the Rhythm podcast episode on 2025 ESC-EHRA Atlas on Heart Rhythm Disorders!

Join experts <a href="/DanielScherr3/">Daniel Scherr</a>, Michal Farkowski, <a href="/simovicst/">Stefan Simović</a> &amp; <a href="/veramasloo/">Vera Maslova</a> as they discuss current landscape of #EP in Europe 🇪🇺

🔗
EHRAPresident (@ehrapresident) 's Twitter Profile Photo

#EHRAtopicweek on 2025 ESC-EHRA atlas on heart rhythm disorders 💡 Did you know? Access to heart rhythm care across countries shows variation: 🏥 A median of 3.3 hospitals per million people perform EP or device procedures in adults. 👶 In children, 0.3 hospitals per million. 🫀

#EHRAtopicweek on 2025 ESC-EHRA atlas on heart rhythm disorders

💡 Did you know? Access to heart rhythm care across countries shows variation:
🏥 A median of 3.3 hospitals per million people perform EP or device procedures in adults.
👶 In children, 0.3 hospitals per million.
🫀
EHRAPresident (@ehrapresident) 's Twitter Profile Photo

🎙️ New episode of the #EHRA_ESC CardioTalk Podcast is out! This time, we dive into the Practical Compendium of Antiarrhythmic Drugs: A Clinical Consensus Statement 🔊 Tune in as Jose Luis Merino, Stefan Simović & Augusto Meretta share key insights and discuss what this important

🎙️ New episode of the #EHRA_ESC CardioTalk Podcast is out!

This time, we dive into the Practical Compendium of Antiarrhythmic Drugs: A Clinical Consensus Statement 

🔊 Tune in as <a href="/joselmerino/">Jose Luis Merino</a>, <a href="/simovicst/">Stefan Simović</a> &amp; <a href="/AugustoMeretta/">Augusto Meretta</a> share key insights and discuss what this important
EHRAPresident (@ehrapresident) 's Twitter Profile Photo

🚀 The new #EHRA_ESC Practical Compendium of Antiarrhythmic Drugs updates the classic Vaughan–Williams classification and makes it easier to apply in daily practice ✨ Key highlights: 🔹 Expanded Classes: Adds Class 0 (HCN channel blockers like ivabradine) and subdivides Classes

🚀 The new #EHRA_ESC Practical Compendium of Antiarrhythmic Drugs updates the classic Vaughan–Williams classification and makes it easier to apply in daily practice

✨ Key highlights:
🔹 Expanded Classes: Adds Class 0 (HCN channel blockers like ivabradine) and subdivides Classes